- Home
- / NanoVation Therapeutics
NanoVation Therapeutics
NanoVation Therapeutics Summary
Company Summary
- Overview
- NanoVation Therapeutics (NTx) is a research company that delivers genetic medicines for human tissues. Its technologies focus on developing lipid nanoparticles (LNPs) for nucleic acid delivery.
- Type
- Private
- Status
- Active
- Founded
- 2020
- Website
- https://nanovationtx.com/
Table of Contents
Key People
Jayesh Kulkarni, Co-Founder and Chief Scientific Officer
Don Enns, Chief Business Officer
Wendy E. Lamson, Chief Intellectual Property Officer
